However, a new CAR-T cell therapy called obecabtagene autoleucel could change this situation. CAR-T therapy (Chimeric Antigen ...

Researchers advance CAR T cell therapy for solid tumors by innovating ways to overcome the unique barriers of solid tumor ...

T-cell therapy is a revolutionary immunotherapy approach in which T cells are genetically modified to express a receptor that ...

A $2.3 million National Cancer Institute grant will fund a University of Cincinnati Cancer Center study to develop a new ...

INT2104 is a novel in vivo chimeric antigen receptor (CAR) gene therapy designed to generate CAR-T and CAR-NK cells in the patient’s body to target CD20-expressing malignant B cells Interim ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new ...

These findings suggest that KIR2DS2-positive (KIR2DS2+) natural killer (NK) cells could be an attractive therapeutic target ...

Dual ON/OFF-switch chimeric antigen receptor controlled by two clinically approved drugs. Proceedings of the National Academy of Sciences , 2024; 121 (44) DOI: 10.1073/pnas.2405085121 Cite This Page : ...